
March 26, 2018 Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical

March 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

March 23, 2018 Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical

March 23, 2018 Manufacturing and Production, Medical Communications India, medical waste, pharma

March 23, 2018 Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical

March 23, 2018 Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical

March 22, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

March 21, 2018 Medical Communications, Research and Development ABPI, UK, biotech, brexit, drugs, pharma, pharmaceutical

March 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, pharma, tokyo

March 21, 2018 Medical Communications, Research and Development J&J, JJ, Johnson & Johnson, biotech, cfo, drugs, pharma, pharmaceutical

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

March 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Round, MSD, Merck, Merck KGaA, Working Life, pharma

March 19, 2018 Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

March 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten

March 16, 2018 Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical